Curaleaf's New Share Repurchase Program to Enhance Shareholder Value

Curaleaf Launches Share Repurchase Program

On April 16, 2026, Curaleaf Holdings, Inc., a prominent international supplier of cannabis products, announced the initiation of a normal course issuer bid (NCIB) to repurchase up to 34,388,831 of its subordinate voting shares. This program, which has been approved by the Toronto Stock Exchange (TSX), marks a strategic move to enhance shareholder value and reflects the company's confidence in its operational strength and long-term strategy.

The repurchase program will span a twelve-month period starting from April 20, 2026, and is expected to conclude by April 19, 2027. This buyback represents approximately 5% of the subordinate voting shares that were outstanding as of April 10, 2026, encompassing an estimated total market value of around $83 million, based on the closing price of shares on the TSX from April 14, 2026.

Boris Jordan, the Chairman and CEO of Curaleaf, commented on the initiative, emphasizing its importance in returning value to shareholders while also underscoring the company's robust business strategy. “This share repurchase program is a meaningful way to return value to our shareholders and reflects our confidence in the strength and durability of our strategy,” he stated.

Under the established NCIB, Curaleaf is permitted to conduct purchases through the facilities of the TSX and may use alternative trading systems in Canada if applicable. The company’s management believes that there may be times when shares trade at prices that do not accurately reflect their intrinsic value. In such instances, buying back these shares is seen as a prudent use of the company's financial resources.

According to TSX regulations, Curaleaf can buy a maximum of 210,139 subordinate voting shares per day, except for block purchase exemptions. This cap corresponds to 25% of the average daily trading volume over the preceding six months, which averaged around 840,559 shares. A designated broker, ATB Cormark Capital Markets, has been appointed to execute these buybacks under the NCIB.

While the specific timing and share price of purchases will depend on market conditions, the NCIB does not mandate Curaleaf to acquire a set number or dollar amount of shares. The company retains the right to modify or terminate the program at any time, adhering to regulatory standards and legislation governing securities.

After reporting its first-quarter financial results for the period ending March 31, 2026, Curaleaf expects to begin purchasing shares under this program. Moreover, shares bought back through the NCIB will be canceled, further decreasing the overall share count.

This initiative comes at a time when Curaleaf has positioned itself as a leader in the cannabis industry, boasting a strong portfolio of brands including Curaleaf, Select, Grassroots, Find, Dark Heart, and Anthem. With a commitment to providing high-quality products and outstanding service, Curaleaf is expanding its footprint across the medical and adult-use markets internationally.

As a publicly traded company, Curaleaf is listed under the symbol CURA on the TSX and CURLF on the OTCQX market, showcasing its dual-market strategy and broad-reaching presence within the cannabis sector. Curaleaf’s mission is to enhance lives through the cultivation and sharing of cannabis products, demonstrating its dedication not only to consumer satisfaction but also to shareholder investments.

In summary, Curaleaf's share repurchase program is a structured approach to strengthen investor confidence while reinforcing the company's commitment to sustainable growth and profitability in the evolving cannabis landscape.